Table 3.
Factors associated with variation in EQ-5D score: results from the UK tariff.
| Variable | Women | Men | Total | |||
|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 1 | Model 2 | Model 1 | Model 2 | |
| Constant | 0.7527 *** | 0.7478 *** | 0.8357 *** | 0.8347 *** | 0.8205 *** | 0.8167 *** |
| Female gender | NA | NA | NA | NA | −0.0570 *** | −0.0561 *** |
| Age at diagnosis | 0.0012 | 0.0012 | 0.0017 | 0.0019 * | 0.0015 * | 0.0015 * |
| Diabetes duration | −0.0010 | −0.0015 | −0.0010 | −0.0007 | −0.0010 | −0.0010 |
| BMI | −0.0066 *** | −0.0065 *** | −0.0054 *** | −0.0053 *** | −0.0060 *** | −0.0060 *** |
| History of macrovascular events | −0.0488 ** | −0.1008 *** | −0.0831 *** | |||
| History of microvascular events | −0.1603 *** | −0.0344 | −0.0830 ** | |||
| AMI history | −0.0032 | −0.0345 | −0.0220 | |||
| Stroke history | −0.0610 | −0.1395 *** | −0.1111 *** | |||
| HF history | −0.0506 | −0.1049 ** | −0.0821 ** | |||
| NAIHD history | −0.0463 | −0.0547 ** | −0.0516 ** | |||
| Kidney disorders history | −0.2482 *** | −0.0110 | −0.1144 ** | |||
| Retinopathy history | 0.0026 | −0.0304 | −0.0119 | |||
| Treatment | ||||||
| Diet (ref) | ||||||
| OHA | 0.0158 | 0.0210 | −0.0210 | −0.0209 | −0.0014 | 0.0010 |
| Insulin ± OHA | −0.0046 | 0.0016 | −0.0189 | −0.0188 | −0.0086 | −0.0055 |
| R-squared | 0.06 | 0.07 | 0.05 | 0.06 | 0.06 | 0.07 |
| N | 760 | 760 | 997 | 997 | 1757 | 1757 |
*,**,***: significant at 10%, 5%, and 1%, respectively.